The Technical Analyst
Concord Medical Services [CCM]
Exchange: New York Stock Exchange Sector: Healthcare Industry: Medical - Care Facilities
Concord Medical Services Price, Forecast, Insider, Ratings, Fundamentals & Signals
25.22% $0.631
/ 26 apr 2024 @ 10:36
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 27.40 mill |
| EPS: | -0.940 |
| P/E: | -0.670 |
| Earnings Date: | Sep 23, 2024 |
| SharesOutstanding: | 43.42 mill |
| Avg Daily Volume: | 0.0103 mill |
| RATING 2024-04-25 |
|---|
| B- |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Neutral | |
| Return On Asset: | Neutral | |
| DE: | Strong Sell | |
| P/E: | Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | n/a | n/a | n/a | |||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.670 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -0.670 | industry: PE 0 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.544 - 0.720 ( +/- 13.93%) |
| ATR Model: 14 days |
Forecast:
12:15 - $0.670
Live Trading Signals (every 1 min)
Forecast
1: 10:45 - $0.637
Forecast 2: 11:35 - $0.670
Forecast 3: 12:15 - $0.670
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $0.631 (25.22% ) |
| Volume | 0.0065 mill |
| Avg. Vol. | 0.0103 mill |
| % of Avg. Vol | 63.10 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For CCM
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
CCM
Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company's other treatments and diagnostic services comprise computed tomography scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2021, it operated a network of 16 cooperative centers based in 13 hospitals. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
Latest Press Releases
2024-04-19 08:31:00 - Press Release
Concord Medical Files 2023 Annual Report On Form 20-f
Beijing , april 19, 2024 /prnewswire/ -- concord medical services holdings limited ("concord medical" or the "company") (nyse: ccm), a healthcare provider specialized in cancer treatment, research, education and prevention in china, today announced that it filed its annual report on form 20-f for the fiscal year ended december 31, 2023 (the "annual report") with the u.s. securities and exchange commission. an electronic copy of the annual report can be accessed on concord medical's investor relations website at http://ir.ccm.cn and on the sec's website at www.sec.gov.
2024-03-28 15:38:00 - Press Release
Canagold Resources Ltd. Announces Closing Of $4.1m Charity Flow Through Financing
Vancouver, british columbia--(business wire)---- $ccm.t #drilling--canagold resources ltd. (tsx: ccm, otc-qb: crcuf, frankfurt: cana) (the "company" or "canagold"), is pleased to announce it has closed a charity flow-through financing with sun valley investments ag (“sun valley”). the company issued 15,700,000 common shares of the company (the “ft share”) that qualify as flow-through shares for the purposes of the income tax act (canada) at a price of $0.2625 per ft share for total gross proceeds of $4,121,500 (the.
2024-02-20 07:00:00 - Press Release
Concord Medical Announces Receipt Of Nyse Non-compliance Letter Regarding Ads Trading Price
Beijing , feb. 20, 2024 /prnewswire/ -- concord medical services holdings limited ("concord medical" or the "company") (nyse: ccm), a healthcare provider specialized in cancer treatment, research, education and prevention in china, today announced that it has received a letter (the "letter") from the new york stock exchange (the "nyse") dated february 12, 2024, notifying the company that it is below compliance standards due to the trading price of the company's american depositary shares (the "adss") and that the applicable cure period for the company to regain compliance expires on august 12, 2024. pursuant to applicable nyse continued listing standards, a company would be considered "below criteria" by the nyse if the average closing price of a security as reported on the consolidated tape is less than $1...
2024-01-09 07:00:00 - Press Release
Concord Medical Announces Listing Of Its Subsidiary On The Stock Exchange Of Hong Kong Limited
Beijing , jan. 9, 2024 /prnewswire/ -- concord medical services holdings limited ("concord medical" or the "company") (nyse: ccm), a healthcare provider specialized in cancer treatment, research, education and prevention in china, today announced the listing of a minority stake of 39,420,200 h shares in concord healthcare group co., ltd. ("concord healthcare"), its subsidiary, at an initial public offer price of hk$14.28 per h share on the main board of the stock exchange of hong kong limited (the "hkse") under the stock code 2453.hk.
2024-01-04 07:30:00 - Press Release
Canagold Appoints Chris Pharness As Senior Vice President Sustainability And Permitting
Vancouver, british columbia--(business wire)---- $ccm.t #drilling--canagold resources ltd. (tsx: ccm, otc-qb: crcuf, frankfurt: cana) (“canagold” or the “company”) announces today that the company has appointed mr. chris pharness as senior vice president sustainability and permitting, effective immediately. mr. pharness has 30 years of experience as an environmental professional. he has a proven record of success in community engagement, relationship building and negotiation, and demonstrated achievement in project.
Latest News
2021-10-18 04:08:00 - PRNewsWire
Concord Medical Is Shortlisted for the "5G+Healthcare" Pilot Project
BEIJING, Oct. 18, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, today announced that two projects of it, Jiahe Cloud Imaging Remote Medical Information Diagnosis Platform ("Jiahe Cloud") and Jiahe Feiyun Intelligent Radiotherapy Cloud Service Platform ("Jiahe Feiyun"), were successfully shortlisted by the "5G+Healthcare" pilot project, which is launched by Ministry of Industry and Information Technology. Jiahe Cloud provides digitized solutions, with remote diagnosis as the core service, for medical institutions.
2021-10-15 18:00:00 - PRNewsWire
Concord Medical Files 2020 Annual Report on Form 20-F
BEIJING, Oct. 15, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers, premium cancer hospitals, and specialty cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2020 (the "Annual Report") with the U.S. Securities and Exchange Commission. An electronic copy of the Annual Report can be accessed on Concord Medical's investor relations website at http://ir...
2021-09-10 07:02:00 - PRNewsWire
Concord Medical Purchases Additional Proton Therapy System for It's Shanghai Concord Cancer Center
BEIJING, Sept. 10, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education, and prevention by establishing proton centers and specialty cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that Shanghai Concord Cancer Center ("SCCC", or the "planned hospital"), a business subsidiary of an important operating platform of the Company, Meizhong Jiahe Medical Science & Technology Development Group Co., Ltd.
2021-08-23 06:10:00 - PRNewsWire
Concord Medical Completes RMB 400 Million Funding Round Led by Consortium Investors
BEIJING, Aug. 23, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializes in cancer treatment, research, education, and prevention by establishing proton centers and specialty cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced an investment of RMB400.0 million (US$62.2 million) in Concord Medical's subsidiary, Meizhong Jiahe Medical Science & Technology Development Group Co., Ltd. ("Meizhong Jiahe") from several investors led by WisdoMont Asset Management (Shanghai) Co., Ltd.
2021-06-11 06:11:00 - PRNewsWire
Concord Medical Officially Opens New Specialty Cancer Hospital in Guangzhou
BEIJING, June 11, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, today announced that its Guangzhou Concord Cancer Center ("GCCC"), which is certified as a tertiary specialty hospital by the National Health Commission, is now in operation. This has marked a major milestone for the Company.
2021-05-25 06:02:00 - PRNewsWire
Concord Medical Receives Notification from NYSE Regarding Delayed Filing of 2020 Annual Report
BEIJING, May 25, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, today announced that as of May 25, 2021, it is late in filing its annual report on Form 20-F for the fiscal year ended December 31, 2020 (the "2020 Annual Report") with the Securities and Exchange Commission (the "SEC"). The Company previously filed a Form 12b-25 with the SEC on April 30, 2021 for late filing of the 2020 Annual Report, pursuant to which the 2020 Annual Report was due to be filed by May 17, 2021.
2021-05-21 16:15:00 - PRNewsWire
Concord Medical Announces Changes in Board of Directors
BEIJING, May 21, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, today announced changes in its board of directors (the "Board"). Mr. Denny Lee ("Mr.
2020-12-28 06:47:00 - PRNewsWire
Concord Medical Announces Divestment of Singapore Concord International Hospital
BEIJING, Dec. 28, 2020 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and...
2020-11-20 04:00:00 - PRNewsWire
Concord Medical Schedules 2020 Annual Meeting of Shareholders
BEIJING, Nov. 20, 2020 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and...
2020-09-08 00:00:00 - https://www.forbes.com
For Monkey Knife Fight, The Value Of Merger With FantasyDraft May Come From Acquiring State Licenses
The true value of Monkey Knife Fight's acquisition of daily fantasy sports company FantasyDraft likely comes in the form of securing additional licenses to operate its contests, most notably in New York.